US Patent

US7863287 — Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines

Formulation · Assigned to Wyeth LLC · Expires 2027-02-28 · 1y remaining

Vulnerability score 65/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a pharmaceutical composition that combines a non-steroidal anti-inflammatory drug, a decongestant, and an antihistamine for treating rhinitis and cold-like symptoms.

USPTO Abstract

The present invention is directed to a pharmaceutical composition and method for the treatment of rhinitis and cold-like symptoms which includes a non-steroidal anti-inflammatory drug (NSAID), a decongestant, and an antihistamine. It has been found that an NSAID enhances the activity of a decongestant and an anti-histamine, thus permitting a reduction in either or both in administration of separate dosage forms. The same enhancement can also occur with an anti-tussitive. Thus, the effective amount of the decongestant or the antihistamine or both is less than about 75% of an amount present in an approved dose of the decongestant or the antihistamine, or both, relative to an amount of the NSAID corresponding to about 100% of the amount present in a normal strength dosage form of the NSAID.

Drugs covered by this patent

Patent Metadata

Patent number
US7863287
Jurisdiction
US
Classification
Formulation
Expires
2027-02-28
Drug substance claim
No
Drug product claim
Yes
Assignee
Wyeth LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.